NCT04739995View on ClinicalTrials.gov

Cost-utility and Physiological Effects of LDN in Patients With Fibromyalgia

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2024

Conditions
Randomized Controlled Trial
Interventions
DRUG

Low-dose naltrexone

4.5 mg LDN/day for 1 year

Trial Locations (1)

08830

Parc Sanitari Sant Joan de Déu (PSSJD), Sant Boi de Llobregat

All Listed Sponsors
collaborator

Carlos III Health Institute

OTHER_GOV

lead

Fundació Sant Joan de Déu

OTHER